Company | Akamai Technologies, Inc. |
Ticker | NASDAQ: AKAM |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) |
Earnings Date | August 6, 2026 (after market close) |
Preparation Date | August 5, 2026 |
Sector ETF Benchmark | IGV (iShares Expanded Tech-Software ETF) |
Key Takeaway: Setup is mixed — consensus is a manageable bar on revenue but the wide EPS guidance range ($1.45–$1.65) creates meaningful uncertainty; the single biggest swing factor is whether CIS revenue ramp and GPU delivery progress in Q2 can offset the margin compression from the unprecedented CapEx surge.
Heading into AKAM's Q2 2026 print, the setup is nuanced: revenue consensus of ~$1.09B sits comfortably within management's guided range of $1.075–$1.10B, making a top-line beat or in-line result the base case, but the wide non-GAAP EPS guidance range ($1.45–$1.65) — driven by the timing and magnitude of GPU deliveries and associated depreciation — leaves the bottom line as the key variable. Management's tone since the May 7 earnings call has been decidedly confident, punctuated by the landmark $1.8B CIS deal and the subsequent $2.6B convertible note offering to fund the build-out, signaling conviction in the demand pipeline. Estimate revisions have been broadly stable since the post-Q1 baseline, with the street largely accepting management's guidance framework rather than diverging materially, though full-year EPS consensus of ~$6.69 sits near the midpoint of the $6.40–$7.15 guided range — a wide band that reflects genuine uncertainty around depreciation timing. The stock surged ~27% on the Q1 print on the $1.8B deal announcement, but has since given back most of those gains, trading near ~$122 heading into the print, suggesting the market has partially de-rated the stock as CapEx intensity and margin compression concerns have weighed on sentiment. The key wildcard is whether management provides any update on additional GPU orders beyond the current guide — the Q1 call explicitly flagged that the GPU pipeline significantly exceeds existing inventory and that additional orders in H2 2026 are possible but not yet in guidance, which could either be a positive catalyst (more demand) or a negative one (more CapEx, more margin pressure).
Key Takeaway: Consensus is a manageable bar on revenue (within guidance range), but the EPS bar is the bigger swing factor given the wide guided range driven by GPU depreciation timing; CIS revenue growth trajectory is the most watched KPI heading into the print.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Est. | YoY Change | Q2 2026 Guidance | Cons. vs. Guidance Mid |
Total Revenue ($M) | $1,073.6 | $1,043.5 | $1,093.1 | +4.8% YoY | $1,075–$1,100M | +0.3% vs. $1,087.5M mid |
Security Revenue ($M) | $589.8 | $551.9 | $600.6 | +8.8% YoY | High single digits CC growth (FY) | Tracking guidance |
Cloud Infrastructure Services (CIS) Revenue ($M) | $94.6 | $71.5 | $101.7 | +42.3% YoY | ≥50% CC growth (FY 2026) | Tracking / above pace |
Delivery Revenue ($M) | $294.2 | $320.1 | $298.2 | -6.8% YoY | Mid-single digit decline CC (FY) | Tracking guidance |
Non-GAAP EPS (Diluted) | $1.61 | $1.73 | $1.58 | -8.7% YoY | $1.45–$1.65 | -0.8% vs. $1.55 mid |
Non-GAAP Operating Income ($M) | $282.8 | $308.6 | $278.2 | -9.9% YoY | ~25–26% op. margin | Tracking guidance |
Adjusted EBITDA ($M) | $426.7 | $444.4 | $422.6 | -4.9% YoY | ~38–39% EBITDA margin | Tracking guidance |
CapEx — Accrual Basis ($M) | $118.9 | $135.6 | $269.0 | +98.4% YoY | $433–$453M (cash basis) | N/A — accrual vs. cash timing |
Free Cash Flow ($M) | $120.7 | $235.4 | $42.1 | -82.1% YoY | Negative FY 2026 (CapEx surge) | Tracking guidance |
Source: Visible Alpha consensus and actuals data. All figures in USD millions unless noted. CIS = Cloud Infrastructure Services. CC = constant currency. Q2 2026 consensus as of August 5, 2026.
Top KPI #1: Total Revenue | Top KPI #2: Non-GAAP EPS (Diluted)
Quarter | Revenue Reported ($M) | Revenue Consensus ($M) | Rev. Surprise % | EPS Reported | EPS Consensus | EPS Surprise % | Result |
Q1 2026 | $1,073.6 | $1,073.9 | 0.0% | $1.61 | $1.60 | +0.6% | In Line / In Line |
Q4 2025 | $1,094.9 | $1,077.2 | +1.6% | $1.84 | $1.77 | +4.0% | Beat / Beat |
Q3 2025 | $1,054.6 | $1,044.0 | +1.0% | $1.86 | $1.64 | +13.4% | Beat / Beat |
Q2 2025 | $1,043.5 | $1,020.8 | +2.2% | $1.73 | $1.56 | +10.9% | Beat / Beat |
Q1 2025 | $1,015.1 | $1,012.0 | +0.3% | $1.70 | $1.57 | +8.3% | In Line / Beat |
Q4 2024 | $1,019.9 | $1,015.9 | +0.4% | $1.66 | $1.52 | +9.2% | In Line / Beat |
Q3 2024 | $1,004.7 | $1,000.4 | +0.4% | $1.59 | $1.59 | 0.0% | In Line / In Line |
Q2 2024 | $979.6 | $977.5 | +0.2% | $1.58 | $1.53 | +3.3% | In Line / Beat |
Source: Visible Alpha consensus and actuals data. Pattern: AKAM has a strong track record of beating or meeting revenue consensus (8 for 8 over the last 8 quarters), while EPS beats have been consistent and often material — the exception being Q1 2026 where the wide guidance range and CapEx surge compressed the beat to near-zero. The Q2 2026 EPS bar is the lowest in 8 quarters ($1.58 consensus vs. $1.73 a year ago), reflecting the market's acknowledgment of margin headwinds from the GPU build-out.
Key Takeaway: Management's posture has shifted to highly confident since the Q1 print, with the $2.6B convertible note offering (May 18) representing a material post-earnings capital action that signals conviction in the CIS demand pipeline; no formal guidance revision has been issued, but the financing action implicitly validates the upper end of the CapEx and growth outlook.
Metric | Initial Guidance (Q1 2026 Earnings — May 7, 2026) | Revised Guidance | Current Consensus | Note |
Q2 2026 Revenue | $1,075–$1,100M (+3–5% YoY) | — | $1,093.1M | Unchanged; consensus sits near high end of range |
Q2 2026 Non-GAAP EPS | $1.45–$1.65 | — | $1.58 | Unchanged; wide range reflects GPU depreciation timing uncertainty |
Q2 2026 Non-GAAP Op. Margin | ~25–26% | — | ~25.4% (implied by consensus) | Unchanged; significant step-down from ~26.3% in Q1 |
Q2 2026 CapEx (Cash Basis) | $433–$453M (~40–41% of revenue) | — | $269M (accrual basis consensus) | Unchanged; Q2 CapEx jump driven by NVIDIA GPU deliveries beginning + Q1 timing catch-up |
FY 2026 Revenue | $4,445–$4,550M (+6–8% YoY) | — | $4,501.3M | Unchanged; consensus near midpoint |
FY 2026 Non-GAAP EPS | $6.40–$7.15 | — | $6.69 | Unchanged; wide range reflects depreciation timing; consensus near midpoint |
FY 2026 CIS Revenue Growth | ≥50% YoY CC (raised from 45–50%) | — | ~$475M FY (implied ~50%+ growth) | Raised at Q1 earnings; driven by $1.8B deal ramp in H2 2026 |
FY 2026 CapEx (% of Revenue) | ~40–42% of revenue (raised from 23–26%) | — | ~$594.6M (accrual basis consensus) | ↑ Dramatically raised at Q1 earnings; $700M of $1.8B deal CapEx in H2 2026 |
FY 2026 Non-GAAP Op. Margin | ~26% (narrowed from 26–28%) | — | ~26% (implied) | ↓ Narrowed at Q1 earnings; investing ahead of revenue for CIS build-out |
Capital Structure | $1.7B cash + $1B credit facility (as of Q1) | $2.6B convertible note offering (May 18, 2026) | N/A | ↑ Post-earnings capital action; proceeds fund CIS CapEx + ~$350M share buyback |
Key Takeaway: Estimates have been remarkably stable since the post-Q1 baseline — the street has largely anchored to management's guidance midpoints rather than diverging — but the wide EPS range means the consensus estimate carries more uncertainty than the number alone suggests; CIS revenue estimates are tracking at or above the ≥50% growth guidance pace.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (as of May 12, 2026) | Current Consensus (Aug 5, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Earnings Call) | Current Guidance | Guidance Δ | Cons. vs. Guidance Mid |
Total Revenue — Q2 2026 | $1,093.1M | $1,093.1M | 0.0% | $1,075–$1,100M | Unchanged | — | +0.5% vs. mid |
Total Revenue — FY 2026 | $4,500.5M | $4,501.3M | +0.0% | $4,445–$4,550M | Unchanged | — | +0.0% vs. mid |
Non-GAAP EPS — Q2 2026 | $1.59 | $1.58 | -0.6% | $1.45–$1.65 | Unchanged | — | +1.9% vs. mid ($1.55) |
Non-GAAP EPS — FY 2026 | $6.68 | $6.69 | +0.1% | $6.40–$7.15 | Unchanged | — | -0.7% vs. mid ($6.775) |
CIS Revenue — Q2 2026 | $102.0M | $101.7M | -0.3% | ≥50% CC growth (FY) | Unchanged | — | ~42% YoY — tracking to FY pace |
CIS Revenue — FY 2026 | $474.9M | $475.2M | +0.1% | ≥50% CC growth (FY) | Unchanged | — | ~50%+ YoY — at/above guidance floor |
Non-GAAP Op. Income — Q2 2026 | $278.6M | $278.2M | -0.1% | ~25–26% margin | Unchanged | — | ~25.4% — tracking guidance |
Free Cash Flow — FY 2026 | -$68.3M | -$85.5M | -25.1% | Negative (CapEx surge) | Unchanged | — | FCF estimates drifting more negative |
Source: Visible Alpha consensus and actuals data. Post-Q1 baseline as of May 12, 2026 (5 trading days after May 7 earnings). Commentary: The near-zero estimate revisions since the Q1 print reflect the street's acceptance of management's guidance framework. The key risk is that the wide EPS range ($1.45–$1.65) means a $0.10 miss vs. consensus is still within guidance — the market may react more to the qualitative commentary on GPU delivery progress and H2 CIS ramp than to the headline EPS number itself.
Key Takeaway: AKAM surged ~27% on the Q1 earnings day (May 8) driven entirely by the $1.8B CIS deal announcement, but has since given back all gains and then some, underperforming both SPY (+5.4%) and IGV (+12.3%) since the earnings date — the de-rating reflects investor concern about CapEx intensity, margin compression, and the long payback period of the GPU build-out rather than any deterioration in the underlying business.
AKAM vs. IGV (iShares Expanded Tech-Software ETF) vs. S&P 500 (SPY) — Indexed to 100 at May 7, 2026 (Q1 2026 Earnings Date). Source: Yahoo Finance.
Performance Summary (May 7 – Aug 4, 2026): AKAM +5.7% | IGV +12.3% | SPY +5.4%. AKAM's post-earnings spike to ~$161 (May 13 intraday high) on the $1.8B deal euphoria quickly faded as investors digested the CapEx implications. The $2.6B convertible note offering on May 18 initially pressured the stock (dilution concerns), and AKAM has trended lower through June and July, reaching a trough near $107 on July 29 before recovering modestly to ~$122 heading into the Q2 print. The stock's underperformance vs. IGV is notable given the broader software sector rally — suggesting AKAM is being valued more as a capital-intensive infrastructure company than a software/security compounder during this investment phase.
Key Takeaway: Peer commentary from the last 60 days is broadly positive for AKAM's two core businesses: security peers (PANW, CRWD, FTNT) are reporting accelerating demand driven by AI-powered threats and enterprise urgency — a direct tailwind for AKAM's security portfolio; and hyperscaler commentary (AMZN, MSFT, GOOGL) confirms that AI infrastructure demand is exceeding supply and that distributed/edge compute is a structural growth theme — validating AKAM's CIS investment thesis. FSLY's CDN read-through is constructive: strong traffic growth and security momentum are positive for AKAM's delivery and security businesses.
Key Takeaway: The most important development since the Q1 print is the $2.6B convertible note offering (May 18), which materially changes AKAM's capital structure and signals management's conviction in the CIS demand pipeline; the secondary implication is that the company is now explicitly financing its GPU build-out through capital markets rather than solely from operating cash flow, which investors will scrutinize for execution risk.
Key Takeaway: All insider transactions since the Q1 earnings date are 10b5-1 planned sales — no discretionary open-market selling and no open-market buying. The absence of discretionary insider buying despite the stock's significant pullback from its post-earnings highs (~$161 to ~$122) is notable but not alarming given the 10b5-1 plan context; the planned sales are routine and obligation-driven.
Name | Title | Transaction Type | Shares | Date | Note |
Joseph Paul C | EVP — Global Sales | 10b5-1 Planned Sale | 3,100 | July 15, 2026 | Pre-planned; routine 10b5-1 plan execution |
Blumofe Robert | Chief Technology Officer | 10b5-1 Planned Sale | 243 | June 18, 2026 | Pre-planned; routine 10b5-1 plan execution |
Salem-Jackson Kim | EVP, Chief Marketing Officer | 10b5-1 Planned Sale | 2,300 | June 10, 2026 | Pre-planned; routine 10b5-1 plan execution |
Howell Laura | SVP, Chief Accounting Officer | RSU Vest + Tax Withholding Sale | 95 (withheld) | June 12, 2026 | 322 RSUs vested; 95 shares withheld for taxes; not a discretionary sale |
Source: SEC Form 4 filings. Note: All open-market transactions since the Q1 2026 earnings date (May 7, 2026) are 10b5-1 pre-planned sales or RSU-related tax withholding — none are discretionary open-market buys or sells. No open-market purchases were filed during the period. The company itself executed share repurchases as part of the $2.6B convertible note offering (approximately $350M in concurrent buybacks from note purchasers at the offering price on May 18, 2026), which represents the most significant capital return action in the period.